Hyperbaric Oxygen Therapy for Cancer

Hyperbaric Oxygen Therapy Combined with Standard Cancer Treatments

In 2013, over 1.6 million people were diagnosed with cancer and over 500,000 cancer-related deaths occurred in the U.S. alone. Cancer is one of the leading causes of death, worldwide, and new integrated treatments are being utilized to help combat its devastating effects.

Hyperbaric oxygen therapy (HBOT) is now being integrated with traditional cancer therapies like radiation and chemotherapy to achieve optimal treatment outcomes, induce tumor regression, and mitigate the adverse effects of these treatments. Cancer cells thrive in hypoxic conditions, and HBOT has demonstrated efficacy in elevating oxygen levels, weakening tumors, and diminishing their aggressiveness. Studies have illustrated the advantages of HBOT for cancer treatment.

Scroll down to find links to some supporting research articles.

Boost the Effectiveness of Traditional Cancer Treatments with Hyperbaric Oxygen Therapy (HBOT)

Diminish Tumor Aggressiveness with HBOT

Boost Natural Killer Cell Activity and Function with HBOT

Mitigate Side Effects of "Conventional" Cancer Therapies and Treatments with HBOT

Boosts the Effectiveness of Intravenous Cancer Treatments

HBOT for Cancer Prevention

Source: International Hyperbarics Association

The information provided on this website is for educational purposes only and should not be viewed as a substitute for the diagnosis, treatment, or advice of a qualified licensed professional. This website offers general information and does not represent the practice of medicine. We do not take responsibility for how this information is utilized. Additionally, please note that the contents of this website are regularly updated for various reasons. Any statements or implied treatments have not been evaluated or approved by the FDA. It is crucial not to alter, discontinue, or change any medication or treatment without consulting your doctor first. Always seek your doctor’s advice before initiating any new treatment program.

Study Findings: Hyperbaric Oxygen Therapy Inhibits Cancer Progression

Low levels of oxygen in tumor cells, known as tumor hypoxia, signal these cancer cells to stimulate blood vessel formation (angiogenesis) and accelerate growth. This heightened aggressiveness and resistance to chemotherapy and radiation pose significant challenges in cancer treatment. Addressing tumor hypoxia has become a focal point in the medical community, with hyperbaric oxygen therapy emerging as one of the most effective and feasible solutions. The findings of this study are highly encouraging, suggesting that despite differences in cancer subtypes, hyperbaric oxygen therapy exerts a consistent suppressive effect on tumor growth, indicating a shared oxygen-dependent anti-tumor mechanism.

Read the study: “Oxygen-dependent regulation of tumor growth and metastasis in human breast cancer xenografts.”

Research Study: Reviewing the Role of Hyperbaric Oxygen Therapy in Cancer Treatment

Hypoxia, a critical feature of solid tumors, drives enhanced cell survival, angiogenesis, metabolism, and metastasis. Hyperbaric oxygen (HBO) therapy has historically addressed hypoxia-related disorders by increasing oxygen delivery to tissues. Early studies on HBO and cancer focused on whether elevated oxygen levels promoted cancer progression. Concerns arose regarding its potential to stimulate cancer growth or recurrence. However, systematic reviews have deemed HBO safe for patients with malignancies. This review summarizes research on HBO and cancer from 2004 to 2012, suggesting HBO may inhibit certain cancer subtypes. Further exploration of HBO’s effects and mechanisms on tumor oxygenation is warranted.

Read “Hyperbaric oxygen therapy and cancer—a review”.